Related Experiment Video

Updated: May 17, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells

J Jin1, Y Zhang, Y Li

  • 1Department of Pharmacology, Chinese Academy of Medical Sciences, Beijing, China.

Neoplasma
|October 17, 2012
PubMed

Insights

Peptidyl-prolyl isomerase Pin1 (Pin1) overexpression drives melanoma. Suppressing Pin1 in melanoma cells reduced proliferation, invasion, and tumor growth, indicating Pin1 is a potential therapeutic target for melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Peptidyl-prolyl isomerase Pin1 (Pin1) is frequently overexpressed in human cancers, including melanoma.
  • Pin1's role in melanoma oncogenesis and its potential as a therapeutic target require further investigation.

Purpose of the Study:

  • To investigate the role of Pin1 in melanoma development and progression.
  • To evaluate Pin1 as a potential therapeutic target for melanoma treatment.

Main Methods:

  • Pin1 expression was suppressed in the human melanoma cell line A375 using microRNA (miRNA) interference technology.
  • Stable clones with suppressed Pin1 were generated via miRNA plasmid transfection.
  • Proliferation, invasion, and tumorigenic potential in athymic mice were assessed.

Main Results:

  • Melanoma cell clones with suppressed Pin1 exhibited reduced proliferation and invasion in vitro.
  • Tumorigenic potential was suppressed in athymic mice.
  • Pin1 inhibition led to decreased Akt phosphorylation and repressed expression of c-Jun N-terminal kinase and pro-matrix metalloproteinase 2.

Conclusions:

  • Pin1 plays a significant role in melanoma tumorigenesis.
  • Pin1 inhibition demonstrates therapeutic potential for melanoma treatment.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...